img

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

PARP inhibitors are a group of pharmacological inhibitors of the enzyme polymerase ADP ribosome (PARP).They are developed for multiple indications.PARP inhibitors can enhance the efficacy of radiotherapy, alkalization agents and platinum-based chemotherapy by inhibiting DNA damage repair and promoting apoptosis of tumor cells. Parp (Poly Adp-Ribose Polymerase) inhibitors is very effective in treating solid tumors and other diseases.Such as advanced ovarian cancer, fallopian tube cancer and primary peritoneal cancer.
PARP (Poly ADP-ribose Polymerase) Inhibitors report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PARP (Poly ADP-ribose Polymerase) Inhibitors market is projected to reach US$ 21490 million in 2034, increasing from US$ 2861 million in 2022, with the CAGR of 32.8% during the period of 2024 to 2034. Demand from Ovarian Cancer and Breast Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for PARP (Poly ADP-ribose Polymerase) Inhibitors industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, PARP (Poly ADP-ribose Polymerase) Inhibitors key companies include AbbVie, Pfizer, AstraZeneca, GlaxoSmithKline, Clovis Oncology and Everest Pharmaceuticals, etc. AbbVie, Pfizer, AstraZeneca are top 3 players and held % share in total in 2022.
PARP (Poly ADP-ribose Polymerase) Inhibitors can be divided into Olaparib and Talazoparib, etc. Olaparib is the mainstream product in the market, accounting for % share globally in 2022.
PARP (Poly ADP-ribose Polymerase) Inhibitors is widely used in various fields, such as Ovarian Cancer, Breast Cancer and Other,, etc. Ovarian Cancer provides greatest supports to the PARP (Poly ADP-ribose Polymerase) Inhibitors industry development. In 2022, global % share of PARP (Poly ADP-ribose Polymerase) Inhibitors went into Ovarian Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PARP (Poly ADP-ribose Polymerase) Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


AbbVie
Pfizer
AstraZeneca
GlaxoSmithKline
Clovis Oncology
Everest Pharmaceuticals
Segment by Type
Olaparib
Talazoparib

Segment by Application


Ovarian Cancer
Breast Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the PARP (Poly ADP-ribose Polymerase) Inhibitors market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, PARP (Poly ADP-ribose Polymerase) Inhibitors introduction, etc. PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of PARP (Poly ADP-ribose Polymerase) Inhibitors market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of PARP (Poly ADP-ribose Polymerase) Inhibitors
1.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Overview
1.1.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Product Scope
1.1.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Status and Outlook
1.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2024-2034)
1.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Region (2024-2024)
1.5 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Forecast by Region (2024-2034)
1.6 Key Regions, PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034)
1.6.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034)
1.6.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034)
1.6.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034)
1.6.4 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034)
1.6.5 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034)
2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market by Type
2.1 Introduction
2.1.1 Olaparib
2.1.2 Talazoparib
2.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Type (2024-2024)
2.2.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Breakdown by Type (2024-2034)
2.3.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Breakdown by Type (2024-2034)
3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Overview by Application
3.1 Introduction
3.1.1 Ovarian Cancer
3.1.2 Breast Cancer
3.1.3 Other
3.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Application (2024-2024)
3.2.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Breakdown by Application (2024-2034)
3.3.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Breakdown by Application (2024-2034)
4 PARP (Poly ADP-ribose Polymerase) Inhibitors Competition Analysis by Players
4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2022)
4.3 Date of Key Players Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market
4.4 Global Top Players PARP (Poly ADP-ribose Polymerase) Inhibitors Headquarters and Area Served
4.5 Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service
4.6 Competitive Status
4.6.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
5.1.4 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (US$ Million) & (2024-2024)
5.1.5 AbbVie Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
5.2.4 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (US$ Million) & (2024-2024)
5.2.5 Pfizer Recent Developments
5.3 AstraZeneca
5.3.1 AstraZeneca Profile
5.3.2 AstraZeneca Main Business
5.3.3 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
5.3.4 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (US$ Million) & (2024-2024)
5.3.5 GlaxoSmithKline Recent Developments
5.4 GlaxoSmithKline
5.4.1 GlaxoSmithKline Profile
5.4.2 GlaxoSmithKline Main Business
5.4.3 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
5.4.4 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (US$ Million) & (2024-2024)
5.4.5 GlaxoSmithKline Recent Developments
5.5 Clovis Oncology
5.5.1 Clovis Oncology Profile
5.5.2 Clovis Oncology Main Business
5.5.3 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
5.5.4 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (US$ Million) & (2024-2024)
5.5.5 Clovis Oncology Recent Developments
5.6 Everest Pharmaceuticals
5.6.1 Everest Pharmaceuticals Profile
5.6.2 Everest Pharmaceuticals Main Business
5.6.3 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
5.6.4 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (US$ Million) & (2024-2024)
5.6.5 Everest Pharmaceuticals Recent Developments
6 North America
6.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Dynamics
11.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Trends
11.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers
11.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges
11.4 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Region (2024-2024)
Table 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size Share by Region (2024-2034)
Table 6. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2024-2024)
Table 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2024-2034)
Table 11. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2024-2024)
Table 24. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2024-2034)
Table 26. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (US$ Million) by Players (2024-2024)
Table 37. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2022)
Table 39. Date of Key Players Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market
Table 40. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players Headquarters and Area Served
Table 41. PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service
Table 42. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. AbbVie Basic Information List
Table 45. AbbVie Description and Business Overview
Table 46. AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
Table 47. Revenue (US$ Million) in PARP (Poly ADP-ribose Polymerase) Inhibitors Business of AbbVie (2024-2024)
Table 48. AbbVie Recent Developments
Table 49. Pfizer Basic Information List
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
Table 52. Revenue (US$ Million) in PARP (Poly ADP-ribose Polymerase) Inhibitors Business of Pfizer (2024-2024)
Table 53. Pfizer Recent Developments
Table 54. AstraZeneca Basic Information List
Table 55. AstraZeneca Description and Business Overview
Table 56. AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
Table 57. Revenue (US$ Million) in PARP (Poly ADP-ribose Polymerase) Inhibitors Business of AstraZeneca (2024-2024)
Table 58. AstraZeneca Recent Developments
Table 59. GlaxoSmithKline Basic Information List
Table 60. GlaxoSmithKline Description and Business Overview
Table 61. GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
Table 62. Revenue (US$ Million) in PARP (Poly ADP-ribose Polymerase) Inhibitors Business of GlaxoSmithKline (2024-2024)
Table 63. GlaxoSmithKline Recent Developments
Table 64. Clovis Oncology Basic Information List
Table 65. Clovis Oncology Description and Business Overview
Table 66. Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
Table 67. Revenue (US$ Million) in PARP (Poly ADP-ribose Polymerase) Inhibitors Business of Clovis Oncology (2024-2024)
Table 68. Clovis Oncology Recent Developments
Table 69. Everest Pharmaceuticals Basic Information List
Table 70. Everest Pharmaceuticals Description and Business Overview
Table 71. Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Products, Services and Solutions
Table 72. Revenue (US$ Million) in PARP (Poly ADP-ribose Polymerase) Inhibitors Business of Everest Pharmaceuticals (2024-2024)
Table 73. Everest Pharmaceuticals Recent Developments
Table 74. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2024) & (US$ Million)
Table 75. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2034) & (US$ Million)
Table 76. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2024) & (US$ Million)
Table 77. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2034) & (US$ Million)
Table 78. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 79. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2024-2024) & (US$ Million)
Table 80. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2024-2034) & (US$ Million)
Table 81. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2024-2024)
Table 82. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2024-2034)
Table 83. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 84. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2024) & (US$ Million)
Table 85. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2034) & (US$ Million)
Table 86. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 87. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2024) & (US$ Million)
Table 88. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2024-2034) & (US$ Million)
Table 89. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Trends
Table 90. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers
Table 91. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges
Table 92. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions: 2022 VS 2034
Figure 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Olaparib
Figure 11. Global Olaparib Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Talazoparib
Figure 13. Global Talazoparib Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Type: 2022 & 2034
Figure 15. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2024-2034)
Figure 16. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2024-2034)
Figure 18. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2024-2034)
Figure 20. Ovarian Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Breast Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Application: 2022 & 2034
Figure 24. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2024-2034)
Figure 25. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2024-2034)
Figure 26. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2024-2034)
Figure 27. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2024-2034)
Figure 28. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2024-2034)
Figure 29. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 30. Global Top 5 and Top 10 Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share in 2022
Figure 31. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2024-2034)
Figure 32. U.S. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 33. Canada PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 34. Germany PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 35. France PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 36. U.K. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 37. Italy PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 38. Russia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 39. Nordic Countries PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 40. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2024-2034)
Figure 41. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 42. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 43. South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 44. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 45. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 46. Australia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 47. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2024-2034)
Figure 48. Mexico PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 49. Brazil PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2024-2034)
Figure 51. Turkey PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 53. UAE PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries